Skip to content

Scientific Technology News

About STN
Contact Us

Top-10
Instrument Industry Deals
Product Launches

FDA approves Roche’s Evrysdi for use in babies under two months with spinal muscular atrophy (SMA)

May 31, 2022May 31, 2022 by /

Share This.....

Share on linkedin

Share on twitter

Share on facebook

Share on google

Related News:

Roche’s Evrysdi (risdiplam) granted FDA priority…
Roche’s Evrysdi (risdiplam) granted FDA priority…
New three-year data for Roche’s Evrysdi (risdiplam)…
New data for Roche’s Evrysdi (risdiplam) demonstrate…
Positive new data for Roche’s Evrysdi in largest…
Consolidated Financial Results for the Three Months…

Category: Acad, Gov/Utilities Tag: Roche

Post navigation

Previous PostMonitor Testing Machines from Anywhere at Any TimeRelease of TRAPEZIUM SATELLITE Testing Machine Remote Monitoring System

Next PostManchester City FC, Xylem Extend Multi-Year Global Partnership to Tackle Water Challenges

Get market data and industry analysis here. Request a complimentary copy.

Related News

Roche’s Evrysdi (risdiplam) granted FDA priority… January 25, 2022
Roche’s Evrysdi (risdiplam) granted FDA priority… January 25, 2022
New three-year data for Roche’s Evrysdi (risdiplam)… April 29, 2022
New data for Roche’s Evrysdi (risdiplam) demonstrate… March 16, 2022
Positive new data for Roche’s Evrysdi in largest… October 12, 2022
Consolidated Financial Results for the Three Months… August 4, 2022
Consolidated Financial Results for the Six Months… November 10, 2022
Consolidated Financial Results for the Nine Months… February 9, 2023
Consolidated Financial Results for the Three Months… August 8, 2023
Consolidated Financial Results for the Six Months… November 9, 2023

© 2024 Scientific Technology News